GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Haleon plc HLN · USD

Health Care · US listing · 🇺🇸 United States

Compare

8.97

-1.86%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$10.79bn

FY2019FY2025

Net income

$1.63bn

FY2019FY2025

Free cash flow

$1.97bn

FY2019FY2025

Shareholders' equity

$16.40bn

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue$10.79bn$11.23bn$11.30bn$10.86bn$9.54bn$9.89bn$8.48bn
Gross profit$6.99bn$6.95bn$6.96bn$6.58bn$5.95bn$5.91bn$4.80bn
Research and development$308.1m$298.0m$311.0m$300.0m$257.0m$304.0m$292.0m
Operating income$2.42bn$2.21bn$2.00bn$1.82bn$1.64bn$1.60bn$897.0m
Net income$1.63bn$1.44bn$1.05bn$1.06bn$1.39bn$1.15bn$655.0m
Diluted earnings per share0.360.310.230.230.300.250.14

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets$32.57bn$34.31bn$34.05bn$34.81bn$34.45bn$34.13bn$35.71bn
Cash and short-term investments$1.32bn$2.25bn$1.04bn$684.0m$414.0m$334.0m$340.0m
Total liabilities$16.12bn$18.09bn$17.33bn$18.36bn$7.97bn$7.91bn$8.30bn
Debt$8.66bn$10.13bn$9.46bn$10.44bn$991.0m$487.0m$642.0m
Shareholders' equity$16.40bn$16.17bn$16.61bn$16.33bn$26.36bn$26.11bn$27.32bn
Shares outstanding4,481m4,608m4,624m4,617m4,617m4,617m4,617m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations$2.29bn$2.30bn$2.10bn$2.06bn$1.36bn$1.41bn$786.0m
Capital spending−$314.9m−$250.0m−$336.0m−$328.0m−$298.0m−$318.0m−$243.0m
Free cash flow$1.97bn$2.05bn$1.76bn$1.74bn$1.06bn$1.09bn$543.0m
Dividends paid−$598.6m−$570.0m−$388.0m−$2.68bn−$1.15bn−$2.37bn−$1.15bn

Latest quarters

By quarter end

Dec 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
Revenue$5.52bn$5.48bn$2.74bn$5.54bn$2.78bn$5.69bn$2.92bn$5.56bn
Gross profit$3.59bn$3.54bn$1.77bn$3.40bn$1.75bn$3.63bn$1.84bn$3.20bn
Operating income$1.25bn$1.20bn$601.5m$1.15bn$705.0m$1.24bn$655.0m$855.0m
Net income$855.7m$806.0m$403.0m$716.0m$485.0m$726.0m$423.0m$362.0m
Diluted earnings per share0.190.180.090.160.110.160.090.08
Cash from operations$1.48bn$1.13bn$513.0m$2.30bn—$842.0m——
Capital spending−$227.0m−$96.0m−$48.0m−$318.0m—−$112.0m——
Free cash flow$1.26bn$1.03bn$465.0m$1.98bn—$730.0m——
Total assets$32.57bn$31.83bn$31.83bn$34.31bn—$33.40bn—$34.05bn
Cash and short-term investments$1.32bn$676.0m$676.0m$2.25bn$531.0m$531.0m$1.04bn$1.04bn
Debt$8.66bn$8.48bn$866.0m$10.13bn—$8.86bn—$9.46bn
Shareholders' equity$16.40bn$15.94bn$15.94bn$16.17bn$16.71bn$16.60bn$16.73bn$16.61bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-0.2%1.7%—
Operating income9.9%8.7%—
Net income15.4%7.3%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin63.3%62.2%61.8%—
Operating margin21.0%19.1%18.4%—
Net margin14.0%11.7%12.1%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings27.830.536.334.9
Price to sales4.23.93.43.4

Market value over time

29 Jul 2022 to 18 Sept 2026, in USD

$32.57bn$41.39bn

Share price return

Finished calendar years

2025202420232022
Return1%19%7%5%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.